TATA Memorial Hospital (TMH) in Mumbai donated urgently required cancer medicines worth of LKR 20 Million to Sri Lanka on 15th July 2022. The donation contains temperature controlled cancer treatment medicines required by Apeksha Cancer Hospital in Maharagama to treat cancer patients awaiting urgent lifesaving medicines. Consulate General of Sri Lanka in Mumbai coordinated with the donor and the relevant Sri Lankan& Indian authorities to facilitate the necessary approvals and clearances to airlift the medical consignment to Sri Lanka on 16th July 2022.
The handing over ceremony was attended by following officials from TATA memorial hospital who organized the donation; Director/ TMH Dr. C.S. Pramesh, , Professor & Head of Division of Pediatric Oncology/ TMH Prof. Dr. Girish Chinnaswamy, Assistant Medical Superintendent /TMH Dr. Vinit Samant, Assistant Professor, Medical Oncology/TMH Dr. Venkata Rama Mohan Gollamudi, General Manager (CSR)/ TMH Sunita Rao, Pharmacist/ TMH Vonod Nair Consul General of Sri Lanka in Mumbai Dr. Valsan Vethody and Consul (Commercial) Sandun Sameera attended the handing over ceremony to accept the donation. While appreciating the invaluable donation made by the TMH at this hour of need for Sri Lanka, Consul General requested further collaboration between TATA Memorial Center and cancer treatment institutes in Sri Lanka to exchange cancer treatment know-how and expertise to uplift the cancer treatments.
Tata Memorial Hospital is amongst the oldest and largest cancer centers in the world, with over 75 years of exceptional patient care, high-quality training and innovative cancer research and is at the forefront of national and global cancer control efforts. It is the national comprehensive cancer center for the prevention, treatment and research on cancer in India
Tata Memorial Centre is a world leader in basic, translational, epidemiologic and clinical cancer research. Research at TMC includes studies to understand cancer biology, large community based screening trials for common cancers and cohort studies, neo adjuvant and adjuvant treatment, perioperative interventions, surgical trials, repurposing drugs and qualitative research to understand the patient journey. In addition, training and education also form a major focus area for TMC which remains the most sought after institution for oncology training in India
